Biomarkers: A Market Briefing

Questions: Discounts, Updates etc.

Pages: 90

Price (Single): $1,995.00

Price (Company): $3,990.00

Publication Date: 2007-01-01

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Personalized medicine, the use of therapies that are targeted to the individual patient, is a reality today, thanks to a growing emphasis on biomarker research. Biomarkers promise a smoother integration of diagnostics and therapeutics, and most importantly a reduction in time and cost for Phase I and II clinical trials.

Anyone looking to take advantage of the opportunities the market for biomarker research offers will find Kalorama’s Biomarkers: A Market Briefing an essential study of this emerging market. Not only does the report explain the types of biomarkers and their myriad diagnostic applications, it tracks current revenue and forecasts revenue for the following diagnostic segments:

Recently, interest in biomarkers has soared due to their proven ability to speed up pharmaceutical R&D efforts. Biomarkers can increase the efficiency and reduce the risks of the drug development process. New trial designs and clear guidelines for using efficacy and safety biomarkers in product development will increase the pace and reduce the cost of developing safe and effective medical products.

Biomarkers have been shown to reduce time and cost for Phase I and II clinical trials by replacing clinical endpoints. This is expected to produce the most profitable segment of the market for companies in this industry. Kalorama’s Biomarkers: A Market Briefing provides detailed information on how this promising application for biomarkers is already shaping the market, producing over $200 million in revenue and expected to quintuple in the next four years. The report details the revenues associated with clinical trials biomarker application through 2009, including data on geographic regional revenues.

Biomarkers: A Market Briefing discusses the major products currently marketed in each disease category as well as the important issues and trends that serious entrants into this market must take notice of. In-depth profiles of need-to-know companies in this market are provided, including:

Kalorama’s trusted information-gathering process provides the most accurate study of the market for biomarkers available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies and in the biomarker arena. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.

Product managers, marketing managers, business development executives, advertising agency or investment firm executives, and information and research center librarians are among the individuals who will find this briefing on the emerging market for biomarkers essential.

Table of Contents

Chapter One: Executive Summary

Chapter Two: Introduction

Chapter Three: Markets

Chapter Four: Company Profiles

 

 

List of Exhibits

 

 

 

Other users found this report page using the following search terms: Biomarkers Personalized medicine market size biomarker biomarkers her2 cancer diagnostic safety cervical allintitle

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.